177 related articles for article (PubMed ID: 35202156)
1. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.
Gregory KS; Mojanaga OO; Liu SM; Acharya KR
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202156
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
Gregory KS; Liu SM; Acharya KR
FEBS Open Bio; 2020 Mar; 10(3):298-305. PubMed ID: 31945264
[TBL] [Abstract][Full Text] [Related]
3. Structural Features of
Gregory KS; Mahadeva TB; Liu SM; Acharya KR
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622602
[TBL] [Abstract][Full Text] [Related]
4. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures of the
Gregory KS; Newell AR; Mojanaga OO; Liu SM; Acharya KR
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077016
[No Abstract] [Full Text] [Related]
6. High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6.
Davies JR; Britton A; Liu SM; Acharya KR
FEBS Open Bio; 2020 Aug; 10(8):1474-1481. PubMed ID: 32654405
[TBL] [Abstract][Full Text] [Related]
7. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
8. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
Kroken AR; Blum FC; Zuverink M; Barbieri JT
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
[TBL] [Abstract][Full Text] [Related]
9. Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors.
Davies JR; Masuyer G; Stenmark P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957706
[TBL] [Abstract][Full Text] [Related]
10. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
Kull S; Schulz KM; Weisemann J; Kirchner S; Schreiber T; Bollenbach A; Dabrowski PW; Nitsche A; Kalb SR; Dorner MB; Barr JR; Rummel A; Dorner BG
PLoS One; 2015; 10(2):e0116381. PubMed ID: 25658638
[TBL] [Abstract][Full Text] [Related]
11. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
13. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
Masuyer G; Davies JR; Stenmark P
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
[TBL] [Abstract][Full Text] [Related]
15. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
Rummel A; Mahrhold S; Bigalke H; Binz T
Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
[TBL] [Abstract][Full Text] [Related]
16. Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay.
James NG; Malik S; Sanstrum BJ; Rhéaume C; Broide RS; Jameson DM; Brideau-Andersen A; Jacky BS
Sci Rep; 2021 Apr; 11(1):7832. PubMed ID: 33837264
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
18. Unique ganglioside recognition strategies for clostridial neurotoxins.
Benson MA; Fu Z; Kim JJ; Baldwin MR
J Biol Chem; 2011 Sep; 286(39):34015-22. PubMed ID: 21849494
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
20. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
